Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

KLRS

Kalaris Therapeutics Inc

Apr 02 • 04:00PM ET

8.07

Dollar change +0.07
Percentage change 0.87	%

Healthcare • Biotechnology • USA • NASD

Held by: VTI VXF

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-11.75	Insider Own	0.00%	Shs Outstand	18.70M	Perf Week	-12.38%
Market Cap	135.07M	Forward P/E	-	EPS next Y	-	Insider Trans	-	Shs Float	18.70M	Perf Month	-17.57%
Income	-58.77M	PEG	-	EPS next Q	-	Inst Own	6.17%	Short Float	0.30%	Perf Quarter	-21.66%
Sales	0.00M	P/S	-	EPS this Y	-	Inst Trans	-	Short Ratio	2.25	Perf Half Y	-56.60%
Book/sh	22.48	P/B	0.36	EPS next Y	-	ROA	-38.00%	Short Interest	0.06M	Perf Year	-56.40%
Cash/sh	7.07	P/C	1.14	EPS next 5Y	-	ROE	-45.37%	52W Range	7.75 - 24.15	Perf YTD	-16.46%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-6.86%	ROI	-51.87%	52W High	-66.58%	Beta	0.67
Dividend TTM	-	Quick Ratio	22.63	Sales past 5Y	-20.00%	Gross Margin	-	52W Low	4.13%	ATR (14)	1.11
Dividend Ex-Date	-	Current Ratio	22.63	EPS Y/Y TTM	72.12%	Oper. Margin	-	RSI (14)	36.59	Volatility	10.43% 12.33%
Employees	6	Debt/Eq	0.00	Sales Y/Y TTM	-	Profit Margin	-	Recom	4.00	Target Price	20.70
Option/Short	No / Yes	LT Debt/Eq	0.00	EPS Q/Q	69.80%	Payout	-	Rel Volume	0.56	Prev Close	8.00
Sales Surprise	-	EPS Surprise	-66.26%	Sales Q/Q	-	Earnings	-	Avg Volume	25.31K	Price	8.07
SMA20	-15.19%	SMA50	-16.86%	SMA200	-43.65%	Trades		Volume	14,063	Change	0.87%

Mar-18-25 04:21PM

Kalaris Announces Closing of Merger with AlloVir

(GlobeNewswire) +16.92%

Kalaris Therapeutics, Inc. is a clinical stage biopharmaceutical company focused on developing and commercializing innovative therapeutics for retinal diseases. It is focusing on developing TH103, a novel anti-VEGF agent targeted at treating neovascular and exudative retinal diseases. The company is headquartered in Palo Alto, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Hagen Brett R	Chief Accounting Officer	Mar 26 '25	Sale	8.97	907	8,135	1,925	Mar 27 07:19 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

KLRS

Kalaris Therapeutics Inc

Upgrade your FINVIZ experience